NDV Therapeutics Corporation
Update：2026/09/15
Industries
Main Industry
Biotechnology
Main Product/Service
1. Research and development of novel stem cell drugs.
2. Research and development of novel immune cell drugs.
(The content above was translated by AI.)
2. Research and development of novel immune cell drugs.
(The content above was translated by AI.)
Founded Year
2020
Unified Business No.
83093264
Status
Active
Number of Employees
0
Total Paid-in
Capital
60,000,000 (NT$)
Location of Company
Taiwan
, Hsinchu County
Information such as company name, company status, responsible person, year of establishment, paid-in capital, and registered address is sourced from the Commercial and Industrial Registration Office of the Ministry of Economic Affairs; listing status includes emerging stock, M&A, and IPO; overseas development is provided by the startup itself.
Notice: This data is compiled from public sources for reference only. We have no direct affiliation with the company and are not their contact person.
Exclusive content for members
Members-only content. Please log in to access.
About the Company
Chengzhi Biomedical is dedicated to the research and development of innovative cell technologies and product development and design. Looking ahead, the company hopes to obtain US FDA and Taiwan TFDA IND approvals in the shortest time possible, and after conducting Phase I/II clinical trials, secure conditional approval and official drug licenses from the Ministry of Health and Welfare to benefit patients.
(The content above was translated by AI.)
(The content above was translated by AI.)
